by German Cancer Research Center Multilineage repression by PROX1 is sufficient and necessary to promote hepatocyte cell fate. Credit: Lim B et al A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational Brain Research (HITBR),...
Tag: <span>Liver cancer</span>
Post
Bile acids impair liver cancer immunotherapy: A dietary supplement may offer relief
by Salk Institute A scientist carrying supplements—like UDCA—climbs a ladder toward a liver containing a bile acid-surrounded tumor. Credit: Salk Institute Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has made an incredible impact on treating cancers in many different organ systems, including the...
Post
Detroit cancer center unveils new device for treating liver cancer at home
by Julia Cardi Credit: Unsplash/CC0 Public Domain A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announced. Called the “TheraBionic P1,” the device works via a small spoon-shaped antenna the patient places on their tongue, said co-inventor Dr. Boris Pasche at a...
Post
Model can predict, stratify liver cancer risk in noncirrhotic chronic hepatitis B
September 18, 2024 by Elana Gotkine A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with chronic hepatitis B (CHB), according to a study published online Sept. 17 in the Annals of Internal Medicine. Gi-Ae Kim, M.D., Ph.D., from Kyung Hee University Hospital in Seoul, South Korea, and...
Post
RARE LIVER CANCER HAS SURPRISING ORIGINS
JUNE 24TH, 2024POSTED BY ROCKEFELLER UNIVERSITY A microscopy image of single cell spatial transcriptomics of FLC tumor cells (red) and stellate cells (green); the latter generates fibrous bands of collagen in response to the FLC cells. (Credit: Rockefeller) TAGS : CANCERLIVERSUNIVERSITY : ROCKEFELLER UNIVERSITY New research sheds light on a rare form of cancer called...
Post
Research team uses AI to predict risk of liver cancer
by UC Davis Credit: Pixabay/CC0 Public DomainA team of UC Davis Health clinicians and data scientists has developed a machine-learning model to better predict which patients are at greater risk of developing a common type of liver cancer, hepatocellular carcinoma (HCC). The findings of their research—published in the journal Gastro Hep Advances—describe how predictive-learning can aid...
Post
Treating liver cancer with microrobots
The idea of injecting microscopic robots into the bloodstream to heal the human body is not new. It’s also not science fiction. Guided by an external magnetic field, miniature biocompatible robots, made of magnetizable iron oxide nanoparticles, can theoretically provide medical treatment in a very targeted manner. Until now, there has been a technical obstacle:...
Post
For diabetes and liver cancer, study suggests new screening guidelines
by Krista Conger, Stanford University Medical Center Collagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—are added (right), the fibers are shorter and more cross-linked, creating conditions that favor cancer progression. Credit: Weiguo FanFor centuries, doctors have used their hands as essential diagnostic tools—exploring joints and palpating...
Post
Liver cancer rates increase in each successive generation of Mexican Americans, study finds
The research, led by the Keck School of Medicine of USC, analyzed risk for the disease across more than 30,000 Mexican Americans, finding third-generation Mexican Americans 66% more likely to get liver cancer than the first generation.Peer-Reviewed Publication KECK SCHOOL OF MEDICINE OF USC In the United States, liver cancer rates have more than tripled...
Post
Gene therapy study identifies potential new treatment for liver cancer
by UC Davis Graphical Abstract. Credit: Molecular Therapy (2023). DOI: 10.1016/j.ymthe.2023.04.019 Gene therapy that induces the body to create microRNA-22 (miR-22), a naturally occurring molecule, successfully treated mice with hepatocellular carcinoma, the most common form of liver cancer. The miR-22 treatment also reduced liver inflammation and produced better survival outcomes with no observable toxicity compared...